Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve the audited Standalone and ....
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has informed the exchanges that its Board of Directors will meet on Thursday, May 29, 2025. The key items on the agenda are: (1) approval of the Standalone and Consolidated Audited Financial Results for the fourth quarter and full financial year ended March 31, 2025; (2) adoption of the Statutory Auditor's reports on these results; and (3) recommendation of a final dividend on equity shares, subject to shareholder approval at the upcoming Annual General Meeting. The intimation has been filed under SEBI LODR Regulation 29. The trading window for dealing in the company's securities remains closed until 48 hours after the financial results are officially declared.
This is a routine pre-results announcement and not a material event in itself. Investors should watch the May 29, 2025 board meeting outcome for the actual FY25 numbers, dividend quantum, and any management commentary, as those will determine the near-term stock reaction.